Hyperkalemia and Ventricular tachycardia

Summary:

Ventricular tachycardia is found among people with Hyperkalemia, especially for people who are male, 60+ old.

The study analyzes which people have Ventricular tachycardia with Hyperkalemia. It is created by eHealthMe based on reports of 22 people who have Hyperkalemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,957 drugs and 2,937 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

What is Ventricular tachycardia?

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 1,290 drugs and 2,097 conditions by eHealthMe. Check the latest studies of Ventricular tachycardia.

On Jul, 13, 2026

22 people who have Hyperkalemia and Ventricular Tachycardia are studied.

Would you have Ventricular tachycardia when you have Hyperkalemia?

Gender of people who have Hyperkalemia and experienced Ventricular Tachycardia *:

female: 16.67 %
male: 83.33 %

Age of people who have Hyperkalemia and experienced Ventricular Tachycardia *:

Common co-existing conditions for these people *:

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 40.91%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 7 people, 31.82%
Cardiac Failure Chronic: 7 people, 31.82%
High Blood Pressure: 6 people, 27.27%
Enlarged Prostate: 6 people, 27.27%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 27.27%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 22.73%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 13.64%
Insomnia (sleeplessness): 2 people, 9.09%

Common drugs taken by these people *:

Common symptoms for these people *:

C-Reactive Protein Increased: 6 people, 27.27%
Alanine Aminotransferase Increased: 6 people, 27.27%
Amylase Increased: 6 people, 27.27%
Blood Bilirubin Increased: 6 people, 27.27%
Aspartate Aminotransferase Increased: 6 people, 27.27%
Fall: 5 people, 22.73%
Constipation: 5 people, 22.73%
Spinal Compression Fracture (fracture due to spinal compression on bone): 5 people, 22.73%
Puncture Site Haemorrhage (puncture site bleeding): 5 people, 22.73%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ventricular tachycardia?

- Check whether Ventricular tachycardia is associated with a drug or a condition

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

Related studies:

Treatments, associated drugs and conditions:

Hyperkalemia (78,084 reports)
Ventricular tachycardia (26,755 reports)

All the drugs that are associated with Ventricular tachycardia:

Ventricular tachycardia (1,290 drugs)

All the conditions that are associated with Ventricular tachycardia:

Ventricular tachycardia (2,097 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ventricular tachycardia and Hyperkalemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.